Uptravi 66215-0718
Generic: Selexipag
Product NDC
66215-0718- Manufacturer
- Actelion Pharmaceuticals Us, Inc.
- Dosage Form
- Injection, Powder, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 29, 2021
- Listing Expires
- December 31, 2027
- Application
- NDA214275
Need to source Uptravi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Selexipag | 1800 ug/10mL |
Drug Class
Prostacyclin Receptor Agonist [EPC]Prostacyclin Receptor Agonist [EPC]Prostacyclin Receptor Agonists [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (66215-718-01) / 10 mL in 1 VIAL, SINGLE-DOSE